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Parkinson’s disease (PD) is a common neurodegenerative disease
characterized by a substantial decrease of dopaminergic neurons
in the substantia nigra pars compacta. The neurological deterio-
ration during PD can be, in part, attributed to elevated levels of
reactive oxygen species (ROS). Radical scavengers have previously
been shown to protect dopaminergic cells from toxic eﬀects
in vitro. Hence, new approaches need to be investigated to improve
the administration of antioxidants in order to provide neuroprotec-
tion. Polymers exhibiting catechol structures oﬀer one such
approach due to their interesting physicochemical properties. In
the present study a photocrosslinkable dopamine-containing poly
(β-amino ester) (DPAE) was synthesized from poly(ethylene glycol)
diacrylate (PEGDA) and dopamine hydrochloride using Michael
type addition. A water-in-oil emulsion technique was used to
photo-crosslink the polymer into spherical microparticles. DPAE
microspheres featured excellent scavenging properties towards
1,1-Diphenyl-2-picryl-hydrazyl (DPPH) radicals in a dose depen-
dent manner and could even reduce the dissolved oxygen content
of physiological solution. Furthermore, the concentrations
required for radical scavenging were shown to be non-toxic
towards dopaminergic SH-SY5Y cells as well as primary astrocytes
and primary embryonic rat ventral midbrain cultures.
Introduction
The death of dopaminergic neurons in patients with PD gives
rise to its clinical features such as a tremor, slowness of
movement and stiﬀness.1,2 Although genetic heritability influ-
ences the disease, its etiology is largely idiopathic with
multiple pathological factors being discussed in the literature:
inflammation, oxidative stress or the accumulation of toxic
protein aggregates.3 Several studies associate mitochondrial
mutation and dysfunction, concomitant with the unregulated
production of reactive oxygen species (ROS), as factors of
neurological deterioration.4 Since current PD therapies only
address the symptoms and not the underlying neurodegenera-
tion, new disease modifying strategies are being sought.
Traditional molecular biology and pharmacological approaches to
new therapies for neurodegenerative disorders have, more
recently, been supplemented with regenerative medicine and
biomaterial constructs.5,6 These include growth factor delivery
systems,7,8 cell microcarriers,9 scaﬀolds,10 hydrogels11 and in
the interest of this work, radical scavenging materials.12–14
Neuromelanin – a by-product of dopamine oxidation, is a
black-brownish pigment which is particularly concentrated in
the dopaminergic neurons of the substantia nigra (SN) and in
the noradrenergic neurons of locus coeruleus.15,16 Deficiencies
in neuromelanin have been observed in the brain stems of
patients aﬀected by PD.16 Neuromelanin interacts with a
variety of organic molecules such as lipids, pesticides and
(neuro)toxic compounds like 4- phenyl-1,2,3,6-tetrahydropyri-
dine (MPTP), and may play a crucial role by modulating the
eﬀects and toxicity of certain compounds.17 Since natural
melanin has attributed chemical complexity, it is diﬃcult to
systematically characterize, so a synthetic analog originating
from dopamine (3,4-dihydroxy-phenylethylamine)13 or L-DOPA
(3,4-dihydroxyphenylalanine)18 has been used as a common
substitute in research. Recently, Ju et al., synthesized melanin-
like nanoparticles from dopamine hydrochloride which feature
radical scavenging abilities.13 The catechol structure in dopa-
mine is presumably the key to radical scavenging properties,
as it is widely observed in many naturally occurring
antioxidants.
The aim of this work was to produce a dopamine contain-
ing polymer that could be photo-crosslinked into bio-
degradable microspheres to act as a radical scavenging
depot. Poly(β-amino esters) are a class of polymer that have
recently received much research attention for biomedical
applications.19–22 Their ease of synthesis, ability to include a
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wide range of monomers, biodegradability (in most cases) and
cytocompatibility (of course monomer dependant), render
them an attractive starting material for new therapeutics.23
Furthermore, catechol containing materials have been much
studied already for biomedical applications.24–26 It was hypo-
thesized that by combining polyethylene glycol diacrylate
(PEGDA) in molar excess with dopamine hydrochloride
(DOPA), a linear polymer chain containing catechol groups
and free vinyl groups could be formed via Michael type
addition. Furthermore it was hypothesized that crosslinked
microspheres of this polymer could have ROS scavenging pro-
perties without causing cellular toxicity.
Results and discussion
The dopamine containing poly(β-amino ester) was successfully
synthesized via Michael type addition in DMSO via the reac-
tion outlined in Fig. 1a. After twelve hours of reaction time,
the resulting pre-polymer from PEGDA and dopamine hydro-
chloride had gained viscosity and turned a pale yellow colour.
After purification, a yield of 68.7% by weight was obtained and
gel permeation chromatography analysis showed the pre-
polymer to have the following molecular weights: Mn =
9.6 kDa, Mw = 11.7 kDa and Đ = 1.22.
1H NMR spectroscopy confirmed that dopamine was
present in the polymer structure (see ESI Fig. S1† – peaks
above 8 ppm). 1H NMR spectroscopy also showed the presence
of free vinyl groups in the structure (peaks at 5.9 and 6.4 ppm)
which were used to crosslink the DPAE pre-polymer into the
microsphere structures. As Anderson and co-workers have pre-
viously reported, poly(β-amino esters) make useful crosslink-
able polymers since their ease of synthesis allows a
combination of monomers to be used.23 Studies in our lab
have previously shown that hyperbranched, dopamine contain-
ing polymers can be synthesized via Michael type addition
when tri-acrylate monomers were used.21,25 In this study
PEGDA700 was used, in conjunction with the mono-amine cate-
chol, dopamine hydrochloride to produce a linear pre-polymer
with good solubility in water (required for the emulsion).
The DPAE microspheres were produced using a water-in-oil
emulsion and the dual-photoinitiator technique described by
Franco et al.,27 was utilized to make well-structured micro-
spheres. Emulsion based microsphere synthesis requires
eﬃcient polymer crosslinking degrees, since phase separation
and droplet coalescence collectively counteract the synthesis of
single spherical polymer particles. The emulsion-based
approach, when 2-hydroxy-2-methylpropio-phenone was
applied as the sole photoinitiator (PI) at a concentration of 1%
(wt/wt) in the prepolymer, resulted in irregular shaped par-
ticles and debris accumulations in the samples (Fig. 2a). The
addition of the hydrophobic PI irgacure I651 into the sur-
rounding oil phase at a final concentration of 3 µg mL−1 sup-
ported the cross linking of the particle surface. The dual-PI
system generated highly spherical particles with completely
cross-linked polymer surfaces (Fig. 2b). In contrast, I651
applied solely in the oil phase in the absence of a second PI in
the prepolymer phase, yielded incomplete crosslinking of the
(mostly) spherical particles (Fig. 2c). The dual PI method was
hence used for both the production of DPAE microspheres and
the PEG control microspheres.
DPAE spheres synthesized in the presence of the surfactant
Pluronic® F-68 at a working concentration of 0.1% displayed a
Fig. 1 Formation of the dopamine containing poly(β-amino ester)
(DPAE) via Michael type addition (a). This DPAE pre-polymer could then
be emulsiﬁed in oil and photocrosslinked into beads ready for ﬁltration
and collection (b). SEM images show spherical beads formed from PEG
(c) or DPAE (d).
Fig. 2 Microsphere formation via a water-in-oil emulsion followed by
UV crosslinking. Light microscopy images of microspheres formed using
only the hydrophilic photoinitiator (PI) in the pre-polymer solution (a),
with both the hydrophilic PI in the pre-polymer and hydrophobic PI in
the oil phase (b), or only the hydrophobic PI in the oil phase (c), showing
how the dual PI method results in the best microsphere formation,
without coalescence (black arrows) or debris (*). The addition of pluro-
nic to the emulsion vastly reduced the size of the spheres formed and
thus increased the usable yield.
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significantly diﬀerent particle size distribution (Fig. 2d). The
addition of the surfactant shifts the distribution to the left
resulting in a reduced mean diameter of 52.68 µm, and a
smaller median value within the range of 40–45 µm. The
maximum diameter was reduced to 164.51 µm allowing a far
greater number of spheres after the 100 µm mesh size fil-
tration process (see ESI Fig. S2 and S3† for final size distri-
butions of filtered DPAE and PEG spheres respectively).
The ability of the DPAE microspheres to scavenge ROS was
analysed using the 2,2-diphenyl-1-picrylhydrazyl (DPPH)
assay13,28 which gives fast detection of radical electron transfer
by catechol groups.29 DPAE spheres at a concentration of
[3500 mL−1] scavenged 14% ±3% of the DPPH radicals in
relation to the control within 30 min of incubation (Fig. 3a).
At DPAE sphere concentrations of [5250 mL−1] and
[7000 mL−1], 47% ±9% and 56% ±5% of the radicals were
eliminated respectively. In contrast, PEG spheres added at
[7000 mL−1] resulted in only 5% ±1% of the radicals being. As
shown in Fig. 3a, the free radical activity of DPAE microspheres
increased in a dose-dependent manner up to 56%, which was
slightly higher than the activity of ascorbic acid [10 µM] – a
well-known antioxidant. Bulk preparations of the crosslinked
DPAE pre-polymer (i.e. not microspheres, but crosslinked
macroscale droplets of 1–2 µL with a pre-determined weight
crosslinked on parafilm) were analysed to see if they aﬀected
the dissolved oxygen concentration of PBS. At these vastly elev-
ated quantities, the bulk DPAE caused a decrease in the dis-
solved oxygen content of PBS (Fig. 3b) via the redox reaction
occurring via the catechol group. The DPAE colouration
(turning black) can be observed in the cuvette as shown in the
insert in Fig. 3b, which occurs in a dose dependent manner.
However, preparations of microspheres at 3500 or 7000
spheres per mL (the same concentrations as the DPPH radical
scavenging assay) caused only a slight drop in the dissolved
oxygen content of PBS (Fig. 3c). Although the DPAE micro-
spheres were originally designed for use as a biodegradable
ROS scavenging depot, a degradation assay performed in PBS
at 37 °C for a period of three weeks showed no significant
mass loss (see ESI Fig. 4†). Though this is not typical of
poly(β-amino esters), careful analysis of the degradation profiles of
the polymer library compiled by Anderson et al., showed that
while most exhibited complete mass loss after 56 days, a few
combinations of monomers did not.23 Of particular interest
for this study was that the phenol containing vinyl monomer
showed a far slower degradation behaviour than most of the
others tested. This lack of degradation of the DPAE micro-
spheres means that they could also be a useful additive for
in vitro cell culture for ROS scavenging without aﬀecting intra-
cellular processes. Conversely, the cross-linkable nature of
these materials may allow smaller material formulations such
as nanotubes30 or be included for the functionalization of
nanomaterials.31
To assess the feasibility of the use of DPAE for applications
in Parkinson’s disease research, the cytotoxicity of the DPAE
microspheres was analysed in comparison to PEG micro-
spheres. SH-SY5Y cells were used as they are a commonly used
in vitro model of dopaminergic neurons for Parkinson’s disease
research.32 In addition, primary rat astrocytes33 and embryonic
(E14) rat midbrain cultures were also used, since they are fre-
quently transplanted into neurotoxin rodent models of Parkin-
son’s disease.10 No reduction in cell metabolic was observed for
either cell type as determined using the PrestoBlue cell viability
reagent in comparison to the untreated cells (100% viable)
Fig. 3 DPAE scavenges radicals and reduces dissolved oxygen content
in PBS. Microspheres scavenge the DPPH stable radical (a) in a dose
dependent manner up to a level scavenged by 10 µM ascorbic acid (n =
4, error bars represent ±standard deviation, two-tailed Student’s t-test
marking diﬀerence to PEG spheres with p-value <0.001 (***) and
p-value <0.01 (**)) Bulk preparations of the DPAE reduced the dissolved
oxygen content of PBS (b) which results in a darkening of the DPAE due
to oxidation of the catechol group after two days (images of cuvettes –
insert). Microspheres of DPAE, at the same concentrations as used for
the radical scavenging assay and toxicity assays, showed only a slight
decrease in dissolved oxygen content (c).
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(Fig. 4a and b). No morphological diﬀerences were observed
either (Fig. 4c and d), and membrane integrity was not aﬀected
(see ESI Fig. S5†) despite a reasonably dense covering of micro-
spheres on the well surface. The good radical scavenging capa-
bility at concentrations that do not induce toxicity, renders
DPAE worthy of further investigation for neuroprotection in cell
models Parkinson’s disease. Biodegradability could potentially
be introduced via the incorporation of other, non-catechol
primary amines in the reaction procedure to act as a biodegrad-
able “spacer” in the chemical structure.
Conclusions
A dopamine containing polymer was produced via Michael
type addition, which, due to free vinyl groups in the structure,
could be photo-crosslinked. A dual photo-initiator, water-in-oil
emulsion was used to create microspheres of the polymer,
which showed excellent radical scavenging activity, the ability
to reduce dissolved oxygen in PBS and showed no toxicity
towards the three cell types analysed. Such materials could act
as a ROS scavenging depot, and future studies will focus on
degradability and ROS scavenging analysis for neuroprotection
in Parkinson’s disease cell models.
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